china biologic products inc
China Biologic Receives SFDA Approval To Begin Human Fibrinogen Trials
China Biologic Products, Inc. has received SFDA approval to begin clinical trials for human fibrinogen as a treatment for congenital fibrinogen deficiency and acquired fibrinogen deficiency.



